These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31362807)

  • 1. Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016.
    Ireland G; Mandal S; Hickman M; Ramsay M; Harris R; Simmons R
    Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017.
    Ireland G; Simmons R; Hickman M; Ramsay M; Sabin C; Mandal S
    Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
    Hamill V; Wong S; Benselin J; Krajden M; Hayes PC; Mutimer D; Yu A; Dillon JF; Gelson W; Velásquez García HA; Yeung A; Johnson P; Barclay ST; Alvarez M; Toyoda H; Agarwal K; Fraser A; Bartlett S; Aldersley M; Bathgate A; Binka M; Richardson P; Morling JR; Ryder SD; MacDonald D; Hutchinson S; Barnes E; Guha IN; Irving WL; Janjua NZ; Innes H
    BMJ; 2023 Aug; 382():e074001. PubMed ID: 37532284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
    Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
    BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
    Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
    J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.
    Alavi M; Grebely J; Hajarizadeh B; Amin J; Larney S; Law MG; George J; Degenhardt L; Dore GJ
    BMC Infect Dis; 2018 May; 18(1):215. PubMed ID: 29743015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment.
    Etoori D; Simmons R; Desai M; Foster GR; Stuart A; Sabin C; Mandal S; Rosenberg W
    BMC Public Health; 2024 Sep; 24(1):2427. PubMed ID: 39243047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of death among persons diagnosed with hepatitis C infection in the pre- and post-DAA era in England: A record linkage study.
    Simmons R; Ireland G; Ijaz S; Ramsay M; Mandal S;
    J Viral Hepat; 2019 Jul; 26(7):873-880. PubMed ID: 30896055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study.
    Ireland G; Simmons R; Hickman M; Eastwood B; Ramsay M; Mandal S
    Int J Drug Policy; 2019 Oct; 72():55-60. PubMed ID: 31257040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
    Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.
    Krajden M; Cook DA; Wong S; Yu A; Butt ZA; Rossi C; Darvishian M; Alvarez M; Buxton JA; Tyndall M; Janjua NZ
    Int J Drug Policy; 2019 Oct; 72():114-122. PubMed ID: 31229445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.
    Neal KR; ; Ramsay S; Thomson BJ; Irving WL
    Gut; 2007 Aug; 56(8):1098-104. PubMed ID: 17344277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain.
    Juanbeltz R; Pérez-García A; Aguinaga A; Martínez-Baz I; Casado I; Burgui C; Goñi-Esarte S; Repáraz J; Zozaya JM; San Miguel R; Ezpeleta C; Castilla J;
    PLoS One; 2018; 13(12):e0208554. PubMed ID: 30513107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Hepatitis C Virus Infection and Treatment on Mortality in the Country of Georgia, 2015-2020.
    Gvinjilia L; Baliashvili D; Shadaker S; Averhoff F; Kandelaki L; Kereselidze M; Tsertsvadze T; Chkhartishvili N; Butsashvili M; Metreveli D; Gamkrelidze A; Armstrong PA
    Clin Infect Dis; 2023 Aug; 77(3):405-413. PubMed ID: 37099136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
    Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
    J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
    Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
    World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
    Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
    Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.
    Sinn DH; Kang D; Hong YS; Koh KC; Guallar E; Cho J; Gwak GY
    PLoS One; 2021; 16(8):e0255624. PubMed ID: 34343200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.